SGLT2 Rx Tool

This tool was created to help providers understand the benefits and risks of SGLT2 inhibitors for patients with and without diabetes.

General Benefits of SGLT2 Inhibitors

  • Hemoglobin A1C (0.5%)
  • Body weight (5 lbs)
  • Proteinuria (by 50%)
  • Systolic blood pressure (5 mmHg)
  • Do not cause hypoglycemia

Patient-Specific Benefits of SGLT2 Inhibitors

Please enter all required patient information.

Made by Dr. Michael Fralick, Michelle Gyenes, Jason Moggridge, and Andy Zhao © 2022. Funded by BioTalent Canada and Sinai Health Department of Medicine Research Fund.

Version 1.4.0

Provide Feedback